At Northwestern Memorial, the multidisciplinary lung cancer group includes radiologists, pulmonologists, thoracic surgeons, oncologists and pathologists who all contribute their sub-specialty expertise to ensure the highest quality of care for lung cancer patients. This team assures the best therapies are recommended and tailored to the patient’s individual needs, along with providing better understanding and access to innovative or relevant clinical trials.
“We will continue to promote smoking cessation as the primary strategy for lung cancer prevention,” said Malcolm DeCamp, MD, chief of division of thoracic surgery at Northwestern Memorial and Fowler McCormick Professor of Surgery at Northwestern’s Feinberg School of Medicine. “But, we have an effective screening technique that we must promote throughout the entire community to detect lung cancer in its earliest stage.”
The criteria developed from the NLST recommends that current and former smokers aged 55 to 74 who have smoked for 30 pack years or more, should be offered low dose CT screening. Prior to the NLST, no screening test for lung cancer had proven effective in reducing lung cancer mortality.
Northwestern Medicine® is the shared vision that joins Northwestern Memorial HealthCare and the Feinberg School in a collaborative effort to transform medicine through quality healthcare, academic excellence and scientific discovery.
To learn more about lung cancer screening at Northwestern Memorial, visit http://www.nmh.org/lungcancerscreening. To schedule an appointment, please call 312-926-0779.